Familial Hypercholesterolemia Retrospective Evaluation for Discovery (FHRED)

Overview

About this study

The purpose of this study is to identify individuals who may have a condition called Familial Hypercholesterolemia (FH) by using different datasets and methodologies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Current participant in an affiliated study or dataset (Table 3.1.1)
Age 18 years or greater
Able to provide informed consent
Eligibile for Casecade Screening (IRB 15-005013)

Exclusion Criteria:

Children will be allowed to participate in the registry, as will pregnant women. This is not an interventional study thus there will be no risk to the mother or neonate. Other vulnerable study populations will be excluded.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Iftikhar Kullo, M.D.	Closed for enrollment	Contact information: David Kochan Kochan.David@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Iftikhar Kullo, M.D.

Closed for enrollment

Contact information:

David Kochan

Kochan.David@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials